Global Peripheral Arterial Disease Market
HealthcareServices

Peripheral Arterial Disease Market Trends Report 2025 – For Business Development and Strategy Teams

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Forecast for the Peripheral Arterial Disease Market Growth in 2025?#_x000D_

The size of the market for peripheral arterial disease has seen significant growth in the past few years. The market, which is projected to increase from $4.36 billion in 2024 to $4.76 billion in 2025, will experience a compound annual growth rate (CAGR) of 9.2%. The historic growth trend can be credited to advancements in medical devices, the emergence of gene and regenerative therapy, the rise of pharmacogenomics, and the influence of digital health and remote monitoring._x000D_

_x000D_

#What Is the Forecast for the Peripheral Arterial Disease Market Size Through 2029?#_x000D_

In the forthcoming years, a significant surge in the market size of peripheral arterial disease is anticipated. The projected growth rate will elevate to $6.62 billion in 2029, with an annual compound growth rate (CAGR) of 8.6%. The increase in the predicted period can be credited to factors such as interdisciplinary care teams, less invasive intercessions, lifestyle alterations, and exercise regimens. Dominant trends within this period will involve vascular tele-rehabilitation, multi-faceted pain control, advancements in wound care, and public health advocacy campaigns._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp_x000D_

_x000D_

#What are the Key Market Players in Peripheral Arterial Disease Market and How They’re Evolving?#_x000D_

Major companies operating in the peripheral arterial disease market are Cardinal Health Inc., Johnson and Johnson Limited, Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, B. Braun SE, Terumo Corp., Cook Medical LLC, Penumbra Inc., Shockwave Medical Inc., AngioDynamics Inc., Cardiovascular Systems Inc., ACIST Medical Systems Inc., SurModics Inc., Endologix Inc., BioVentrix Inc., QT Vascular Ltd., Avinger Inc., Mercator MedSystems Inc., VentureMed Group Ltd., Eximo Medical Ltd., LimFlow SA, Contego Medical LLC._x000D_

_x000D_

#What Are the Primary Growth Drivers in the Peripheral Arterial Disease Market?#_x000D_

The increasing occurrence of heart disease is fuelling the expansion of the peripheral arterial disease industry. Heart disease commonly affects the primary arteries serving the heart muscle. Treatment for peripheral arterial disease can provide cardiac patients with better blood circulation, lowered cardiovascular risk, relief from symptoms, and an overall elevation in life quality. For example, as per the Australian Bureau of Statistics (ABS) report in December 2023, in 2022, close to 1.3 million people or 5.2% of individuals suffered from diseases affecting the heart, stroke, and vascular system. Furthermore, in April 2022, the American College of Cardiology, a non-profit medical association from the US, projected that the chances of developing ischemic heart disease are set to surge by 30.7% to affect 29 million people by 2025. Consequently, the escalating frequency of heart diseases is stimulating the peripheral arterial disease market’s growth.

Peripheral Arterial Disease Market Driver: Rising Incidence of Diabetes Expected to Further Fuel The Peripheral Arterial Diseases.

_x000D_

 

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12999&type=smp_x000D_

_x000D_

#What Are the Leading Segments in the Global Peripheral Arterial Disease Industry?#_x000D_

The peripheral arterial disease market covered in this report is segmented –_x000D_

_x000D_

1) By Treatment Type: Devices, Catheters, Drugs, Other Types_x000D_

2) By Route of Administration: Oral, Parenteral, Other Route of Administrations_x000D_

3) By End User: Hospitals, Specialty Clinics, Others End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Devices: Stents, Balloons, Atherectomy Devices_x000D_

2) By Catheters: Drug-Eluting Catheters, Balloon Catheters, Guidewires_x000D_

3) By Drugs: Antiplatelet Agents, Anticoagulants, Vasodilators_x000D_

4) By Other Types: Surgical Interventions, Lifestyle Modification Programs, Endovascular Therapy_x000D_

_x000D_

#What Are the Key Market Trends in the Peripheral Arterial Disease Industry?#_x000D_

In an effort to increase treatment effectiveness, better patient outcomes, and decrease recovery durations for vascular conditions, leading firms in the peripheral arterial disease industry are concentrating on producing cutting-edge medical equipment, such as the intravascular lithotripsy (IVL) catheter. The Intravascular Lithotripsy (IVL) catheter is a medical tool that helps treat calcified arterial blockages by delivering precise shockwaves to disaggregate the calcium, thereby improving blood flow and increasing vessel flexibility during angioplasty treatments. For example, in September 2024, Shockwave Medical, Inc., a medical tech company based in the U.S., introduced the Shockwave E8 peripheral IVL catheter. This medical device, designed to treat peripheral arterial disease, delivers targeted intravascular lithotripsy that employs sonic waves to disintegrate calcium deposits in arterial walls. This unique methodology not only reinstates blood flow but also substantially reduces trauma to adjacent tissues. The superior design of this catheter facilitates smoother navigation through intricate vascular structures, making it appropriate for a plethora of patients._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report_x000D_

_x000D_

#What Is the Regional Outlook for the Peripheral Arterial Disease Market?#_x000D_

North America was the largest region in the peripheral artery disease market in 2024. The regions covered in peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12999_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the peripheral arterial disease market, and how is it changing globally?_x000D_

2. Who are the major companies in the peripheral arterial disease market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the peripheral arterial disease market right now?_x000D_

4. Which products or customer segments are growing the most in the peripheral arterial disease market?_x000D_

5. What factors are helping or slowing down the growth of the peripheral arterial disease market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model